Other
CII
Morphinum
FDA Label NDC 10191-1004
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Remedy Makers for the product Morphinum (NDC 10191-1004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, warning, indications:, warning:, directions (adult/children), inactive ingredients, other information, questions and comments:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Warning
"The FDA has not derermined that the product is safe, effective and not misbranded for its intended use."
Indications:
PAIN, NAUSEA, DIARRHEAN NEURITIS, OR OTHER INDICATIONS
Warning:
Use only if cap and seal are unbroken. Keep this and all medication out of reach of children. If symptoms persist for more than 3 days or worsen, discontinue (STOP) use and consult your physician. As with any drug. If you are pregnant or nursing (breast-feeding) a baby, seek the advise of a health professional before using this product. Store tightly closed in a cool area.
Directions (Adult/Children)
Dissolve 3 or 4 pellets in mouth or under tongue 3 times a day or as directed by a physician. Children 2 years and older take 1/2 adult dose.
Inactive Ingredients
Lactose and Sucrose. Free from yeast, wheat, corn and soy.
Other Information
Contains approx. 158 - 165 pellets.
Questions And Comments:
(877) REM4YOU Fax (909) 594-4205 Pomona, CA. 91768 USA www.remedymakers.com
Warnings And Precautions
CAUTION: Federal law prohibits dispensing without prescription.
Package Label.Principal Display Panel
Morphinum 12x (Morphinum12x)
* Please review the disclaimer below.
